SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10230I thought same thing and looked to see what was hiding. EPS pretty good on adusRobohogs-5/1/2008
102295 PR's from Sepracor this morning. Q results, Lunesta down (when was the lasrkrw-5/1/2008
10228UCB to sue Synthon over alleged Xyzal patent infringement April 16, 2008: 03:19 Icebrg-4/16/2008
10227Private company Inotek writes: <i>To best execute on the Company’s develIcebrg-4/10/2008
10226This is my first post since Halloween Day. I still have a modest, underwater poRobohogs-4/8/2008
10225At their Cowen conference presentation, mgt said they have an agreement with Breidos-3/18/2008
10224Looks like 4Q07 rev actual $340m vs. 350ishm. 2008 rev guessitmate 1.35b to 1.4kenhott-2/29/2008
10223Sepracor will have to restate earnings due to internal investigation of Medicaidtuck-1/28/2008
10222>>Nycomed's Ciclesonide to be Commercialised in the United States by Stuck-1/28/2008
10221<reply> Happy new year indeed! lol. Just a couple of comments. KSR waskenhott-1/23/2008
10220Sepracor Exec. Won't Lose Sleep Over Retirement Written by Matthew L. BIcebrg-1/5/2008
10219Sepracor Inc. and Bial Announce Exclusive Licensing Agreement for Development anIcebrg-1/2/2008
10218In a way a relatively cheap way to get him out of the way. ErikIcebrg-12/31/2007
10217Didn't realize being an executive chairman paid so well. BOSTON, Dec 31 (Rrkrw-12/31/2007
10216$300 Mil.+ Lunesta Account in Play; McCann Defends December 14, 2007 By Kamau HiIcebrg-12/15/2007
10215Annual re-ranking announced of Nasdaq-100 index NEW YORK, Dec 14 (Reuters) - ThIcebrg-12/15/2007
10214Another roadblock on the way to market. Gary Lynch and NBIX picks up its second Icebrg-12/13/2007
10213Sepracor Inc. Announces Completion of SEC Investigation Tuesday November 27, 7:0Icebrg-11/27/2007
10212Sepracor's Lunesta will Dominate Market Share in the Insomnia Market By 2010Icebrg-11/16/2007
10211Sanofi is cruel :-) Sepr is downsizing yet they recently signed a deal to buirkrw-11/2/2007
10210Cramer 11/01 Cramer told a viewer Sepracor's (SEPR) main drug is slowing beDoc Bones-11/2/2007
10209OT: Irony. So I pulled up the Sepracor 8-K today related to the downsizing of ttuck-11/1/2007
10208Sepracor "neutral," target price raised Wednesday, October 31, 2007 9Icebrg-11/1/2007
10207<<<Any idea if the key support/scientists who did most of the filing workrw-10/31/2007
10206Jim, You have been followng this longer than I. One of the supposed competitivRobohogs-10/31/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News